NL176168C - PROCEDURE FOR THE PREPARATION OR MANUFACTURE OF A PHARMACEUTICAL PREPARATION AND METHOD FOR THE PREPARATION OF USEFUL NEW SUBSTITUTED 1-(4-AMINOPHENYL)-2-AMINO-ETHANOL DERIVATIVES WHICH, EXCEPT AN ANALGETIC, UTERUS SPASMOLYTIC AND ANTI-SPASTIC ACTIVITY, HAVE RELATIVE STRIPES IN PARTICULAR HAVE A BETA2 MIMETIC AND/OR BETA1 BLOCKING ACTIVITY. - Google Patents

PROCEDURE FOR THE PREPARATION OR MANUFACTURE OF A PHARMACEUTICAL PREPARATION AND METHOD FOR THE PREPARATION OF USEFUL NEW SUBSTITUTED 1-(4-AMINOPHENYL)-2-AMINO-ETHANOL DERIVATIVES WHICH, EXCEPT AN ANALGETIC, UTERUS SPASMOLYTIC AND ANTI-SPASTIC ACTIVITY, HAVE RELATIVE STRIPES IN PARTICULAR HAVE A BETA2 MIMETIC AND/OR BETA1 BLOCKING ACTIVITY.

Info

Publication number
NL176168C
NL176168C NLAANVRAGE7316139,A NL7316139A NL176168C NL 176168 C NL176168 C NL 176168C NL 7316139 A NL7316139 A NL 7316139A NL 176168 C NL176168 C NL 176168C
Authority
NL
Netherlands
Prior art keywords
preparation
activity
beta1
analgetic
spasmolytic
Prior art date
Application number
NLAANVRAGE7316139,A
Other languages
Dutch (nl)
Other versions
NL176168B (en
NL7316139A (en
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2261914A external-priority patent/DE2261914C3/en
Priority claimed from DE19732345442 external-priority patent/DE2345442C2/en
Priority claimed from DE19732351281 external-priority patent/DE2351281C3/en
Priority claimed from DE2354961A external-priority patent/DE2354961C2/en
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NL7316139A publication Critical patent/NL7316139A/xx
Publication of NL176168B publication Critical patent/NL176168B/en
Application granted granted Critical
Publication of NL176168C publication Critical patent/NL176168C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
NLAANVRAGE7316139,A 1972-12-18 1973-11-26 PROCEDURE FOR THE PREPARATION OR MANUFACTURE OF A PHARMACEUTICAL PREPARATION AND METHOD FOR THE PREPARATION OF USEFUL NEW SUBSTITUTED 1-(4-AMINOPHENYL)-2-AMINO-ETHANOL DERIVATIVES WHICH, EXCEPT AN ANALGETIC, UTERUS SPASMOLYTIC AND ANTI-SPASTIC ACTIVITY, HAVE RELATIVE STRIPES IN PARTICULAR HAVE A BETA2 MIMETIC AND/OR BETA1 BLOCKING ACTIVITY. NL176168C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE2261914A DE2261914C3 (en) 1972-12-18 1972-12-18 Amino-phenyl-ethanolamines and their acid addition salts, processes for their production and pharmaceuticals
DE19732345442 DE2345442C2 (en) 1973-09-08 1973-09-08 d- and l-phenylethanolamines and their salts, manufacturing processes and drugs based on them
DE19732351281 DE2351281C3 (en) 1973-10-12 1973-10-12 Aminophenylethanolamine derivatives, their production and use
DE2354961A DE2354961C2 (en) 1973-11-02 1973-11-02 Process for the preparation of aminophenylethanolamines

Publications (3)

Publication Number Publication Date
NL7316139A NL7316139A (en) 1974-06-20
NL176168B NL176168B (en) 1984-10-01
NL176168C true NL176168C (en) 1985-03-01

Family

ID=27431596

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7316139,A NL176168C (en) 1972-12-18 1973-11-26 PROCEDURE FOR THE PREPARATION OR MANUFACTURE OF A PHARMACEUTICAL PREPARATION AND METHOD FOR THE PREPARATION OF USEFUL NEW SUBSTITUTED 1-(4-AMINOPHENYL)-2-AMINO-ETHANOL DERIVATIVES WHICH, EXCEPT AN ANALGETIC, UTERUS SPASMOLYTIC AND ANTI-SPASTIC ACTIVITY, HAVE RELATIVE STRIPES IN PARTICULAR HAVE A BETA2 MIMETIC AND/OR BETA1 BLOCKING ACTIVITY.

Country Status (20)

Country Link
JP (1) JPS5811852B2 (en)
KR (1) KR850001916B1 (en)
BG (1) BG21209A3 (en)
CA (1) CA1027955A (en)
CH (2) CH605622A5 (en)
DD (1) DD111574A5 (en)
DK (1) DK150502C (en)
FI (1) FI62052C (en)
FR (1) FR2210414B1 (en)
GB (1) GB1445740A (en)
HK (1) HK6680A (en)
HU (1) HU168701B (en)
IE (1) IE39065B1 (en)
IL (1) IL43837A (en)
MY (1) MY8800145A (en)
NL (1) NL176168C (en)
NO (1) NO137782C (en)
PL (1) PL97194B1 (en)
RO (1) RO63025A (en)
SE (1) SE409700B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430486A1 (en) * 1978-07-07 1980-02-01 Oreal Disinfectant deodorant stick for hanging in WC - is in cage within sealed cartridge which is removed by tearing strip defined by rupture lines
NL8105170A (en) * 1980-12-10 1982-07-01 Thomae Gmbh Dr K NEW PHENYL ALKYLAMINS, METHOD FOR THE PREPARATION THEREOF AND THE USE THEREOF AS MEDICINES.
FR2515177A1 (en) * 1981-10-28 1983-04-29 Lafon Labor 1-Amino:phenyl 2-isopropyl or tert.butyl-amino 1-ethanol derivs. - used as antidepressants, sedatives, vasodilators and hypotensives, without hyper:reactivity and excitation side effects
GB8426191D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds
US4943591A (en) * 1984-10-17 1990-07-24 Glaxo Group Limited Dichloroaniline derivatives
US4863959A (en) * 1985-10-17 1989-09-05 American Cyanamid Company Anthranilonitrile derivatives as useful agents for promoting growth, improving feed efficiency, and for increasing the lean meat to fat ratio of warm-blooded animals
ES2021267B3 (en) * 1985-10-17 1991-11-01 American Cyanamid Co METHOD FOR PROMOTING GROWTH, IMPROVING FOOD EFFECTIVENESS AND ACCELERATING FATNESS IN HOT BLOOD ANIMALS.
GB8603475D0 (en) * 1986-02-12 1986-03-19 Glaxo Group Ltd Chemical compounds
GB8703007D0 (en) * 1987-02-10 1987-03-18 Glaxo Group Ltd Chemical compounds
JPS63290852A (en) * 1987-02-10 1988-11-28 グラクソ、グループ、リミテッド Compound
EP2423188B1 (en) * 2003-08-29 2021-03-10 Mitsui Chemicals Agro, Inc. Intermediates in the preparation of agricultural/horticultural insecticides and method for using the same
GB0604822D0 (en) * 2006-03-09 2006-04-19 Arakis Ltd The treatment of inflammatory disorders and pain
CN100497296C (en) * 2006-07-07 2009-06-10 沈阳药科大学 Novel optical activity phenylethanolamine compounds and preparation method thereof
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) * 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses

Also Published As

Publication number Publication date
KR830000207A (en) 1983-03-30
IE39065L (en) 1974-06-18
JPS5811852B2 (en) 1983-03-04
PL97194B1 (en) 1978-02-28
FI62052B (en) 1982-07-30
IE39065B1 (en) 1978-08-02
IL43837A0 (en) 1974-03-14
DK150502B (en) 1987-03-16
FI62052C (en) 1982-11-10
CA1027955A (en) 1978-03-14
CH614188A5 (en) 1979-11-15
JPS4994640A (en) 1974-09-09
FR2210414B1 (en) 1977-01-28
KR850001916B1 (en) 1985-12-31
HU168701B (en) 1976-06-28
BG21209A3 (en) 1976-03-20
HK6680A (en) 1980-03-07
NO137782C (en) 1978-04-26
IL43837A (en) 1977-02-28
MY8800145A (en) 1988-12-31
DK150502C (en) 1987-10-26
DD111574A5 (en) 1975-02-20
AU6369373A (en) 1975-06-19
GB1445740A (en) 1976-08-11
RO63025A (en) 1978-12-15
SE409700B (en) 1979-09-03
NO137782B (en) 1978-01-16
NL176168B (en) 1984-10-01
NL7316139A (en) 1974-06-20
FR2210414A1 (en) 1974-07-12
CH605622A5 (en) 1978-10-13

Similar Documents

Publication Publication Date Title
NL176168C (en) PROCEDURE FOR THE PREPARATION OR MANUFACTURE OF A PHARMACEUTICAL PREPARATION AND METHOD FOR THE PREPARATION OF USEFUL NEW SUBSTITUTED 1-(4-AMINOPHENYL)-2-AMINO-ETHANOL DERIVATIVES WHICH, EXCEPT AN ANALGETIC, UTERUS SPASMOLYTIC AND ANTI-SPASTIC ACTIVITY, HAVE RELATIVE STRIPES IN PARTICULAR HAVE A BETA2 MIMETIC AND/OR BETA1 BLOCKING ACTIVITY.
NL142328B (en) METHOD OF MANUFACTURE OF A CAPSULE ORAL ADMINISTRATION FOR MEDICAL PURPOSES AND THE CAPSULE SO MANUFACTURED.
FR2340318A1 (en) NEW FORMS OF TRANSITIONAL DRUG PRECURSORS, OF THE XANTHINE DERIVATIVE TYPE.
NL166399C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANTI-INFLAMMATORY EFFECT, THE MEDICINAL PRODUCTS OBTAINED THEREOF, AND METHOD FOR PREPARING ANTI-INFLAMMATICALLY ACTIVE.
NL7513854A (en) METHOD OF PREPARATION OF A MEDICINAL PRODUCT WITH BRONCHOSPASMOLYTIC ACTION CONTAINING ONE OR SOME DERIVATIVES OF 2-AMINO-1- (3,5-DIHYDROXYPHENYL) -ETHANOL AND THE USE OF THIS METHODS OF METHODS-BRONCHOSPASMOLYTIC ACTION AND PROCEDURE FOR PREPARING NOSPICID 2-AMINO-1- (3,5-DIHYDROXYPHENYL) -ETHANOL DERIVATIVES.
NL7804388A (en) NEW N- / 1- (3-BENZOYLPROPYL) -4-PIPERIDYL / SULPHONIC AMIDS AND METHOD FOR THE PREPARATION THEREOF.
NL160816C (en) PROCESS FOR THE PREPARATION OF 4,4-DICHLOR OR 4,4-DI-BROMOOM PYRAZOLONES, PROCESS FOR PREPARATION OF A PREPARATION AND PREPARATION THEREFORE OBTAINED.
NL7600945A (en) PROCEDURE FOR PREPARING OXIM ETHERS, AS WELL AS PROCEDURE FOR PREPARING A MEDICINAL PRODUCT WITH INCLUDING LOCAL ANALGETIC AND SPASMOLYTIC ACTION.
NL148312B (en) PROCESS FOR THE PREPARATION OF A DRUG THAT OF CERTAIN 1-quinolyl-2-ALKYLAMINOETHANOLDERIVATEN AND / OR acid addition salts CONTAINS AND USING THIS PROCESS OBTAINED SHAPED DRUGS, AND METHOD FOR PRODUCING SUCH MEDICINAL derivatives and their acid addition salts .
NL7709007A (en) METHOD FOR PREPARING NEW COMPOUNDS WITH ANTI-BACTERIAL ACTION, AND FORMED PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS
NL180564C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANTI-IGNITION AND ANALGETIC EFFICACY, AND METHOD FOR PREPARING ANTI-IGNITION AND ANALGETIC EFFECTS
NL7705839A (en) PROCESS FOR PREPARING A MEDICINAL PRODUCT AGAINST EYE DISEASES AND THE MEDICINAL PRODUCT THEREFORE.
NL175292C (en) METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH ANALGETIC ACTION, AND A METHOD FOR PREPARING A 2-AMINOTETRALINE DERIVATIVE OR A PHARMACEUTICALLY ACCEPTABLE ACID SALT THEREOF
NL176173C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANALGETIC AND ANTI-INFLAMMATORIC ACTION AND THE USE THEREOF NEW AROYL-THIOPHENE-ACETIC ACID DERIVATIVES.
NL148897B (en) PROCEDURE FOR PREPARING PHARMACEUTICAL PREPARATIONS WITH SPASMOLYTIC ACTION, THEREFORE FORMED PHARMACEUTICAL PREPARATIONS AND PROCEDURE FOR PREPARING 3- (DI- (2-THIENYL) METHYLIDES) -N-METHINEDLPATERIDES.
NL166474B (en) PROCESS FOR PREPARING NEW N-ACYL-3-INDOLYLACETIC ACID DERIVATIVES, WITH ANTI-INFLAMMATORY, ANTI-ANTI-ANTI-PAINT EFFECTS, A PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION PREPARED FOR A PREPARED PREPARATION, PREPARED THEREFORE,
NL175418C (en) PROCESS FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH A SEDATIVE, ANXIOLITIC AND ANTI-CRAMPING EFFECT CONTAINING A SUBSTITUTED ETHYLAMINE DERIVATIVE, PREPARED FROM THE USE OF THIS METHOD, HAS BEEN PREPARED, HAS BEEN PREPARED FROM THIS PROCESS
NL178591C (en) METHOD FOR PREPARING A 6-DESOXYTETRACYCLINE, AND METHOD FOR PREPARING OR MANUFACTURING A THERAPEUTIC PREPARATION CONTAINING SUCH TETRACYCLINE
NL7804470A (en) METHOD FOR PREPARING A CETYLPYRIDINIUM SALT, METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION AND FORMED THERAPEUTIC PREPARATION.
NL161439C (en) METHOD FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS WITH NERVOUS ACTIVITY CONTAINING A 5-(3-DIMETHYLAMINO-PROPYLIDENE)-5H-DIBENZO A,D CYCLOHEPTENE-N-OXIDE, AND METHOD FOR THE PREPARATION OF SUITABLE COMPOUNDS THEREOF.
NL150780B (en) PROCESS FOR THE PREPARATION OF AMPHETAMINE DERIVATIVES WITH ANOREXIGENIC ACTION, PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ANOREXIGENIC ACTION AND FORMED MEDICINAL PRODUCT.
NL147437B (en) PROCESS FOR THE PREPARATION OF MEDICINAL PROPERTIES CONTAINING ANTI-SEROTONIN, ANTI-HISTAMINE, ANTI-EMETIC AND ANALGETIC ACTION, THE PREPARED MEDICINAL PRODUCT, AND FOR THE PREPARATION OF THE ACTIVE COMPOUNDS USED FOR THESE MEDICINAL PRODUCTS.
DK480177A (en) 1- (4-PHENOXY-PHENYL) -1,3,5-TRIAZINDERIAZINE DERIVATIVES PROCEDURES FOR THE MANUFACTURE OF IT AND THEIR USE AS MEDICINES
NL171806C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT WITH ANALGETIC AND / OR ANTI-COUGHING ACTION, AND METHOD FOR PREPARING A BENZAZONINE COMPOUND
NL171576C (en) PROCESS FOR PREPARING A MEDICINAL PRODUCT WITH BETA-ADRENERGICALLY BLOCKING EFFECT THAT A 1-PHENOXY-2-HYDROXY-3-AMINOPROPEN DERIVATIVE AND / OR A PHARMACEUTICALLY ACCEPTABLE ACID THEREFORE INCLUDED THEREFORE THEREFORE THEREFORE PREPARATION OF THESE DERIVATIVES AND THEIR ACID ADDITION SALTS.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
V4 Discontinued because of reaching the maximum lifetime of a patent